HomeCompareCRSB vs PFE

CRSB vs PFE: Dividend Comparison 2026

CRSB yields 5.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $21.8K in total portfolio value· pulled ahead in Year 9
10 years
CRSB
CRSB
● Live price
5.00%
Share price
$40.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$688.45
Full CRSB calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CRSB vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRSBPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRSB + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRSB pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRSB
Annual income on $10K today (after 15% tax)
$425.00/yr
After 10yr DRIP, annual income (after tax)
$585.18/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,734.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRSB + PFE for your $10,000?

CRSB: 50%PFE: 50%
100% PFE50/50100% CRSB
Portfolio after 10yr
$38.7K
Annual income
$13,473.59/yr
Blended yield
34.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CRSB
No analyst data
Altman Z
-0.8
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRSB buys
0
PFE buys
0
No recent congressional trades found for CRSB or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRSBPFE
Forward yield5.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$27.8K$49.6K
Annual income after 10y$688.45$26,258.71
Total dividends collected$6.0K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CRSB vs PFE ($10,000, DRIP)

YearCRSB PortfolioCRSB Income/yrPFE PortfolioPFE Income/yrGap
1$11,200$500.00$9,153$693.39+$2.0KCRSB
2$12,507$523.36$8,593$849.25+$3.9KCRSB
3$13,929$546.22$8,336$1,066.78+$5.6KCRSB
4$15,473$568.51$8,437$1,384.80+$7.0KCRSB
5$17,146$590.20$9,013$1,875.40+$8.1KCRSB
6$18,957$611.24$10,306$2,680.72+$8.7KCRSB
7$20,916$631.61$12,820$4,101.38+$8.1KCRSB
8$23,031$651.27$17,673$6,826.70+$5.4KCRSB
9← crossover$25,314$670.22$27,543$12,591.86$2.2KPFE
10$27,774$688.45$49,560$26,258.71$21.8KPFE

CRSB vs PFE: Complete Analysis 2026

CRSBStock

Cornerstone Community Bancorp operates as the bank holding company for Cornerstone Community Bank that provides commercial, industrial, agricultural and personal credit, and other banking services in Tehama, Shasta, Butte, and Glenn counties and the surrounding areas in California. The company offers personal banking products comprise personal checking and savings accounts that include standard and gold savings, money market, health savings, individual retirement accounts, and certificate of deposit; debit and personal credit cards; and personal loans, such as personal secured and unsecured term loans, savings and CD secured loans, personal lines of credit, auto loans, home equity lines of credit, and residential construction loans. It also provides business banking products, including business checking and savings accounts, money market accounts, and certificate of deposit; business debit and credit cards; business loans, such as business, equipment, commercial real estate, commercial construction, small business administration loans, business line of credit, and letter of credit; and business services comprising online banking, automated sweeps, positive pay, remote deposit capture, ACH origination, and messenger and merchant card services. In addition, the company offers account services, such as online banking and bill pay, mobile banking, E-statements, and mobile payments. It serves small and mid-size businesses, including professional service firms, real estate developers and investors, and not-for-profit organizations and their owners, as well as individuals. The company was incorporated in 2014 and is headquartered in Red Bluff, California.

Full CRSB Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CRSB vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRSB vs SCHDCRSB vs JEPICRSB vs OCRSB vs KOCRSB vs MAINCRSB vs JNJCRSB vs MRKCRSB vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.